Anna McCraney, AuD · Anna McCraney, AuD. Disclosures Ototronix Glasscock Hearing Center. Cochlear...
Transcript of Anna McCraney, AuD · Anna McCraney, AuD. Disclosures Ototronix Glasscock Hearing Center. Cochlear...
RETHINKING UNAIDED WORD RECOGNITIONSCORE MINIMUMS TO INCREASE NUMBER OF
IMPLANT CANDIDATES
Anna McCraney, AuD
Triggers to CI Eval Recommendation
Patient dissatisfied with HAs
PTA What level?
PB max What level?
Mild
Moderate
Profound
Hybrid CI
CI
Severe
Mod-Severe
Normal
Severe
Audiometry Based Screening
86% of patients with monosyllabic word recognition scores at or below 32% (or 44% for patients with private insurance) would meet candidacy requirements for cochlear implantation1
Patients with a monosyllabic word recognition test score of ≤40% and/or pure‐tone thresholds (250, 500, 1,000 Hz) of ≥75 dB have a high likelihood of meeting candidacy criteria. 1
PB max [%] < 4FPTA [dB] – 82
i.e. PB max = 50%, referral recommended when 4FPTA = 58 dBHL or higher
1. Gubbels, S, Gartrell, B, Ploch, J, Hanson, K. Can routine office‐based audiometry predict cochlear implant evaluation results? Laryngoscope 2017
2. Hoppe, U, Hast, A, Hocke, T. Audiometry‐Based Screening Procedure for Cochlear Implant Candidacy. OtolNeurotol 2015
Path to Implantation
Accepted treatment tenant Patients with WR > 50% receive sufficient aided
benefit
Primary CI trigger Unaided WR ≤ 50‐60%
Aided WRS vs. Speech Recognition
* McRackan T, Ahlstrom J, Clinkscales W, Myer T, Dubno J. Clinical Implications of Word Recognition Differences in Earphone and Aided Conditions. Otol Neurotol 2016.
SD (SRT + 40)
Aided WRS vs. Speech Recognition
* McRackan T, Ahlstrom J, Clinkscales W, Myer T, Dubno J. Clinical Implications of Word Recognition Differences in Earphone and Aided Conditions. Otol Neurotol 2016.
SD (SRT + 40)
Aided WRS vs. Speech Recognition
* McRackan T, Ahlstrom J, Clinkscales W, Myer T, Dubno J. Clinical Implications of Word Recognition Differences in Earphone and Aided Conditions. Otol Neurotol 2016.
• Patients with similar PB max can have wide differences in aided speech recognition
• PB max cannot be used to reliably predict hearing aid outcomes
• Testing with HAs must be performed to determine actual patient benefit.
SD (SRT + 40)
* McRackan T, Ahlstrom J, Clinkscales W, Myer T, Dubno J. Clinical Implications of Word Recognition Differences in Earphone and Aided Conditions. Otol Neurotol 2016.
SD (SRT + 40)
Aided Benefit vs. Cochlear Potential
Some patients with PB max >50% may qualify for CI or HCI
Aided AzBio vs. Unaided CNC
* McRackan T, et al. Earphone and Aided Word Recognition Differences in Cochlear Implant Candidates. Otol Neurotol 2018.
Aided AzBio vs. Unaided CNC
* McRackan T, et al. Earphone and Aided Word Recognition Differences in Cochlear Implant Candidates. Otol Neurotol 2018.
CI Candidates
50
50
Aided CNC vs. Unaided CNC
* McRackan T, et al. Earphone and Aided Word Recognition Differences in Cochlear Implant Candidates. Otol Neurotol 2018.
50
HCI or CI Candidates
185 Total Ears81 CI Candidates
* Hoppe, U, Hast, A, Hocke, T. Audiometry‐Based Screening Procedure for Cochlear Implant Candidacy. OtolNeurotol 36:1001‐1005, 2015
CI Candidacy
* Hoppe, U, Hast, A, Hocke, T. Audiometry‐Based Screening Procedure for Cochlear Implant Candidacy. OtolNeurotol 36:1001‐1005, 2015
CI Candidacy185 Total Ears
81 CI Candidates
* Hoppe, U, Hast, A, Hocke, T. Audiometry‐Based Screening Procedure for Cochlear Implant Candidacy. OtolNeurotol 36:1001‐1005, 2015
Audiology’s Walking Wounded185 Total Ears
81 CI Candidates
57
30% of CI candidates had PB max ≥50%
24
Unveiling Candidates
More potential implant candidates exist, disguised as patients with “aidable” loss Could increase identified candidates by not
limiting aided testing to only those with PB max < 50‐60%
CI Candidates with PB max >60%
* Chang, J, et al. Comparison of MAXUM and Hearing Aid Performance to Word Recognition Performance Obtained under Earphones. Otol Neurotol
AVERAGE CNCMAXUM: 67%Hearing Aid: 15%Improvement: 42%
HCI Candidates with PB max >60%AVERAGE WRS
MAXUM: 82%Hearing Aid: 44%Improvement: 38%
* Hunter, et al; Laryngoscope, The Ototronix Maxum MEI for Severe HF SNHL, 2016
Conclusion
Aided benefit cannot be reliably predicted from PB max so it MUST be measured Early and regular aided testing has the
potential to significantly increase the number of identified potential candidates Expand our armamentarium to include CIs,
HCIs and MEIs for patients with PB max >50%
It all starts with testing…
“If we don’t ask the question, we won’t get the answer.”
James Jerger, PhD